Trauma Devices – Market Insights – Asia Pacific

In recent years, the Asia Pacific trauma device market has been negatively impacted by various events, including the COVID-19 pandemic, which diminished procedure volumes at the time, as well as the introduction of the volume-based procurement policy by the Chinese government, which is placing downward pressure on ASPs in the country. Nonetheless, favorable demographics and rising adoption of innovative devices will continue to support overall market growth through 2032.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region from 2019 to 2032.

The implementation of volume-based procurement in China has impacted the overall trauma device market. 

How has this government initiative affected the market?

What aspects of the initiative have helped drive growth potential in the trauma device space? 

How has volume-based procurement affected MNCs versus local competitors? 

Improving trauma care in China and India and the expanding aging populations in these countries will drive overall market growth.

What other factors have supported procedure volumes in the Chinese and Indian trauma device market?

How do trends compare to other Asia Pacific markets for trauma devices? 

The introduction of new policies and strong competition between MNCs and domestic players has led to price declines in the Asia Pacific trauma device market.

Which local competitors have been able to capture notable shares within the Asia Pacific trauma device space?

What are the key competitive strategies used by domestic competitors to remain competitive in the trauma device market?

What other strategies are MNCs using to remain competitive in the face of strong pricing pressures?

How has reimbursement affected purchasing preferences in this region, and how will that evolve during the forecast period?

Table of contents